Medicare Enrolled
Dr. Chris Marino, M.D.
Neurology · Fort Myers, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Marino from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Marino?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Marino
Dr. Chris Marino is a neurology specialist in Fort Myers, FL, with 21 years of NPI registration. Based on federal Medicare data, Dr. Marino performed 20,052 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Marino received a total of $11,021 from 75 pharmaceutical and/or device companies across 616 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Marino is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 5% volume in FL
$11,021 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 69258 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗20,052
Medicare services
Top 5% in FL for neurology
Not available
Unique patients (not deduplicated)
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection (Xeomin), per unit An injection of incobotulinumtoxin A, a botulinum toxin type A product, administered in a quantity of one unit. |
10,750 | $4 | $8 |
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
6,900 | $5 | $9 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,092 | $92 | $268 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
266 | $77 | $227 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
199 | $137 | $369 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
155 | $124 | $414 |
| New patient office visit, complex (60-74 min) | 115 | $174 | $531 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
89 | $10 | $62 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
86 | $1 | $7 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
77 | $109 | $358 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
71 | $302 | $911 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
56 | $62 | $184 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 39 | $63 | $184 |
| Chemical nerve block for facial paralysis Injection of a chemical agent to paralyze specific nerves or muscles on the side of the face. |
38 | $144 | $431 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
30 | $174 | $589 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
29 | $354 | $1,025 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
28 | $40 | $132 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
19 | $140 | $412 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
13 | $235 | $746 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$11,021
Total received (2018-2024)
Avg $1,574/year across 7 years
Top 26% in FL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
75
Companies
616
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,269
2023
$2,196
2022
$1,963
2021
$1,297
2020
$836
2019
$1,042
2018
$1,418
Payments by company (2024)
ABBVIE INC.
$362
Alexion Pharmaceuticals, Inc.
$189
Novartis Pharmaceuticals Corporation
$160
UCB, Inc.
$159
PFIZER INC.
$139
Amneal Pharmaceuticals LLC
$123
Lundbeck LLC
$112
MITSUBISHI TANABE PHARMA AMERICA, INC.
$92
GE HEALTHCARE
$85
ARGENX US, INC.
$78
EMD Serono, Inc.
$77
Celgene Corporation
$72
Neurocrine Biosciences, Inc.
$69
Lilly USA, LLC
$65
ACADIA Pharmaceuticals Inc
$60
Genentech USA, Inc.
$55
JAZZ PHARMACEUTICALS INC.
$47
GENZYME CORPORATION
$41
TG Therapeutics, Inc.
$41
Teva Pharmaceuticals USA, Inc.
$35
CATALYST PHARMACEUTICALS, INC.
$31
SK Life Science, Inc.
$30
Merz Pharmaceuticals, LLC
$28
Takeda Pharmaceuticals U.S.A., Inc.
$24
REVANCE THERAPEUTICS, INC.
$22
Medtronic, Inc.
$20
Otsuka America Pharmaceutical, Inc.
$20
Eisai Inc.
$17
Kyowa Kirin, Inc.
$16
Top 3 companies account for 31.3% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$901
UCB, Inc.
$833
ACADIA Pharmaceuticals Inc
$653
GENZYME CORPORATION
$492
Sunovion Pharmaceuticals Inc.
$478
Alexion Pharmaceuticals, Inc.
$477
Novartis Pharmaceuticals Corporation
$419
Amgen Inc.
$378
Genentech USA, Inc.
$368
Lundbeck LLC
$350
PFIZER INC.
$304
Allergan, Inc.
$286
Supernus Pharmaceuticals, Inc.
$260
ARGENX US, INC.
$237
Teva Pharmaceuticals USA, Inc.
$223
EMD Serono, Inc.
$215
Eisai Inc.
$201
Amneal Pharmaceuticals LLC
$195
Biohaven Pharmaceuticals, Inc.
$186
Celgene Corporation
$160
US WorldMeds, LLC
$152
GE HealthCare
$149
Neurocrine Biosciences, Inc.
$147
Allergan Inc.
$136
Horizon Therapeutics plc
$131
Lilly USA, LLC
$125
Biohaven Pharmaceutical Holding Company Ltd.
$123
Merz Pharmaceuticals, LLC
$120
Biogen, Inc.
$115
GE HEALTHCARE
$114
SK Life Science, Inc.
$107
MITSUBISHI TANABE PHARMA AMERICA, INC.
$105
Avion Pharmaceuticals
$103
Octapharma USA, Inc.
$101
Alnylam Pharmaceuticals Inc.
$97
Grifols USA, LLC
$96
AbbVie Inc.
$91
Ipsen Biopharmaceuticals, Inc
$81
SANOFI-AVENTIS U.S. LLC
$73
Merz North America, Inc.
$70
E.R. Squibb & Sons, L.L.C.
$69
Avanir Pharmaceuticals, Inc.
$68
CATALYST PHARMACEUTICALS, INC.
$67
Acorda Therapeutics, Inc
$66
Otsuka America Pharmaceutical, Inc.
$65
Sumitomo Pharma America, Inc.
$62
Takeda Pharmaceuticals U.S.A., Inc.
$53
JAZZ PHARMACEUTICALS INC.
$47
Catalyst Pharmaceuticals, Inc.
$44
EISAI INC.
$41
TG Therapeutics, Inc.
$41
Greenwich Biosciences, Inc.
$40
Adamas Pharmaceuticals, Inc.
$37
Kyowa Kirin, Inc.
$35
IMPEL PHARMACEUTICALS INC.
$33
Aprecia Pharmaceuticals, LLC
$32
Abbott Laboratories
$31
Upsher-Smith Laboratories LLC
$28
InSightec,Inc
$28
MDD US Operations, LLC
$27
Corium, LLC
$27
Janssen Pharmaceuticals, Inc
$26
REVANCE THERAPEUTICS, INC.
$22
Almatica Pharma LLC
$22
Medtronic, Inc.
$20
Medtronic USA, Inc.
$15
Zyla Life Sciences, Inc.
$15
Mylan Specialty L.P.
$15
UPSHER-SMITH LABORATORIES LLC
$14
Bayer HealthCare Pharmaceuticals Inc.
$14
PORTOLA PHARMACEUTICALS, INC.
$14
Mallinckrodt LLC
$13
AbbVie, Inc.
$13
ARBOR PHARMACEUTICALS, INC.
$13
Neurelis, Inc.
$12
Top 3 companies account for 21.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aduhelm · Aimovig · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · CREXONT · DAXXIFY · DUOPA · DYSPORT · Dhivy · Dysport · EMGALITY · EPIDIOLEX · Epidiolex · Exablate · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · GILENYA · GLATIRAMER ACETATE · GOCOVRI · GRALISE · Gamunex-C · HYQVIA · Horizant · INBRIJA · INGREZZA · INTELLIS ADAPTIVESTIM · Infinity DBS Pulse Generators · KESIMPTA · KYNMOBI · LEMTRADA · LUMIZYME · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NEXVIAZYME · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · POMPE - DISEASE · Ponvory · Proclaim Family of SCS IPGs · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · REXULTI · RYTARY · Rebif · Rystiggo · SOLIRIS · SPRIX · Soliris · Spritam · TECFIDERA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XEOMIN · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZEPOSIA · Zilbrysq · Zinbryta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
182
County median income
$73,099
Nearest hospital to ZIP centroid (approximate)
GULF COAST MEDICAL CENTER LEE HEALTH
3.4 mi
3.4 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Marino is a mixed practice specialist, with above-average Medicare volume (top 5% in FL), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Marino experienced with botox injection (xeomin), per unit?
Based on Medicare claims data, Dr. Marino performed 10,750 botox injection (xeomin), per unit services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Marino receive payments from pharmaceutical companies?
Yes. Dr. Marino received a total of $11,021 from 75 companies across 616 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Marino's costs compare to other neurologists in Fort Myers?
Dr. Marino's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Marino) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Fort Myers
Browse neurologists in Fort Myers ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in FL
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in FL
Which FL neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
ACADIA Pharmaceuticals Inc Payments to Doctors
See all physicians who received payments from ACADIA Pharmaceuticals Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology